A deep dive into the Asian generic pharmaceutical landscape, comparing India's volume dominance with China's API control and the rise of emerging hubs.
Feb, 9 2026
Mar, 11 2026
Jan, 20 2026
Nov, 18 2025
Oct, 3 2025